NK/T细胞淋巴瘤是一种罕见的高度侵袭性非霍奇金淋巴瘤，其发病率具有地域性、种族性差异，主要集中于亚洲和南美洲 [1] 。NK/T细胞淋巴瘤与EB病毒 ...

“利用该发明专利的培养方法获得的细胞中，分泌杀伤活性相关蛋白GranzymeB的细胞比例不低于90%，而CD3+CD56+和CD3+CD8+细胞比例也不低于总细胞数的40% ...

A massive infiltration of activated macrophages was present in the liver, while neither CD3+ nor CD56+ cells were observed. Serum cytokine levels were: interferon gamma 0.2 IU/ml (normal range ...

北京大学肿瘤医院团队针对血管免疫母细胞性T细胞淋巴瘤(AITL)化疗响应率低的临床难题，通过回顾性分析56例患者外周血淋巴 ...

它有两个臂部：一个臂部结合癌细胞抗原，另一个臂部结合T细胞表面上的CD3。然而，双特异性抗体并不总是足以活化T细胞。T细胞活化是在T细胞受体 ...

它有两个臂部：一个臂部结合癌细胞抗原，另一个臂部结合T细胞表面上的CD3。然而，双特异性抗体并不总是足以活化T细胞。T细胞活化是在T细胞受体 ...

NK细胞绝对数量扩增可达到1000倍以上； 细胞数量的扩增可达到200倍以上； CD3-CD56 + 的比例最高可达到90%以上； 细胞存活率在90%以上； ISO9001、ISO13485双体系认证； GMP制药级生产环境，批次稳定性高。 浓度：2×10 8 beads/ml； 内毒素：<2EU/mL； T细胞活化无需滋养层 ...

We analyzed effector cell numbers on a FACSCanto II (BD Biosciences) using CD45-PerCP, CD19-APC, CD10-FITC, BAFF-R-PE, CD56-FITC, CD16-PE and CD3-APC (BD Biosciences). For expression of CD3 ...

Finally, CD3–phycoerythrin, CD56–phycoerythrin, CD19– peridinin chlorophyll protein cychrome 5.5, and CD5–allophycocyanine (BD Biosciences) were added, and the samples were incubated for ...

There were no significant effects on CD3+CD8+ T cells (P=0.50), CD19+ B cells (P=0.23), or CD3+CD56+ natural killer T cells (P=0.35) after 8 weeks of interleukin-2 treatment. The counts of γ/δ T ...

CD3 (including its subunits CD3ε, CD3δ, CD3γ, and CD3ζ) is the central component of the TCR-CD3 complex and is crucial for recognizing T cells and responding to antigens. Every subunit of CD3 ...

CD20 × CD3 bispecific antibodies bind to both CD20 on malignant B cells and CD3 on T cells, bringing them into close proximity, which triggers T cell-mediated killing of the targeted B cells.